Page last updated: 2024-10-31

midazolam and Intracranial Arteriovenous Malformations

midazolam has been researched along with Intracranial Arteriovenous Malformations in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Intracranial Arteriovenous Malformations: Congenital vascular anomalies in the brain characterized by direct communication between an artery and a vein without passing through the CAPILLARIES. The locations and size of the shunts determine the symptoms including HEADACHES; SEIZURES; STROKE; INTRACRANIAL HEMORRHAGES; mass effect; and vascular steal effect.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bustillo, MA1
Lazar, RM1
Finck, AD1
Fitzsimmons, B1
Berman, MF1
Pile-Spellman, J1
Heyer, EJ1

Other Studies

1 other study available for midazolam and Intracranial Arteriovenous Malformations

ArticleYear
Dexmedetomidine may impair cognitive testing during endovascular embolization of cerebral arteriovenous malformations: a retrospective case report series.
    Journal of neurosurgical anesthesiology, 2002, Volume: 14, Issue:3

    Topics: Adjuvants, Anesthesia; Adult; Cerebral Angiography; Cognition; Dexmedetomidine; Embolization, Therap

2002